LivingWithHemophilia.com Named Best Educational Web Site for Patients

Share Article

Bayer HealthCare receives Gold Award for Excellence in Web development.

This recognition by the Health Information Resource Center confirms that we have created a valuable resource for the community.

The Health Information Resource Center has recognized Bayer HealthCare for excellence in Web site development for its hemophilia patient education Web site, LivingWithHemophilia.com. The site received the highest award for patient education information as part of the 2007 annual World Wide Web Health Awards competition, a program that recognizes the best Web-based health-related content for consumers and professionals.

LivingWithHemophilia.com is an interactive, online resource that provides practical tips and tools for hemophilia patients and their families to help manage life with the disease. The Web site includes an "Ask the Expert" feature, articles from healthcare providers and community leaders and online polls, plus other relevant content developed in partnership with Bayer's Hemophilia Nurse Advisory Board.

"Knowing that hemophilia patients and their caregivers face unique challenges every day, Bayer created LivingWithHemophilia.com to provide an online information and networking tool for members of the hemophilia community," said Terry Tenbrunsel, Vice President, Sales and Marketing, Bayer HealthCare. "This recognition by the Health Information Resource Center confirms that we have created a valuable resource for the community."

The World Wide Web Health Awards is organized by the Health Information Resource Center (HIRC), a national clearinghouse for consumer health information programs and materials. This Web-based health awards is an extension of the HIRC's 14-year-old National Health Information Awards (NHIA), the largest program of its kind in the United States. There were nearly 1,000 entries in this year's National Health Information Awards from hundreds of organizations.

For more information on this award-winning online resource center, visit http://www.LivingWithHemophilia.com.

Contact:
David Freundel
Bayer HealthCare
Tel: (973) 305-5310
E-mail: david.freundel @ bayer.com

About Hemophilia A
Hemophilia A, also known as factor VIII deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is missing or reduced. Hemophilia A, the most common type of hemophilia, is caused by deficient or defective blood coagulation proteins, known as factor VIII. Hemophilia A is characterized by prolonged or spontaneous bleeding, especially into the muscles, joints, or internal organs. Approximately one in 5,000 males born in the United States has hemophilia.

About Bayer HealthCare LLC
Bayer HealthCare LLC is an affiliate of Bayer HealthCare AG, one of the world's leading, innovative companies in the healthcare and medical products industry based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions. The Pharmaceuticals division comprises the following business units: Women's Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology, Primary Care, and Oncology. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. The products enhance well-being and quality of life by diagnosing, preventing and treating diseases.

Forward-looking statements
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties, and other factors could lead to material differences between the actual future results, financial situation, development, or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

i http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=180&contentid=45&rptname=bleeding

BAYER and the Bayer Cross and Living with Hemophilia are registered trademarks of Bayer.
©Bayer HealthCare LLC    092008Y

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Freundel
Visit website